Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
HHS advances womens health, removes misleading FDA warnings on hormone replacement therapy
FEBS Lett (2013) 587:136672
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Incorrect address details were provided at checkout
US$ 22.20
US$ 22.58
US$ 29.28
US$ 28.32
US$ 27.87
US$ 26.30
US$ 23.02
